JP Morgan Chase
PMN icon

JP Morgan Chase’s ProMIS Neurosciences PMN Stock Holding History

JP Morgan Chase’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3
Closed -$29 – 7700
2025
Q3 		$29 Buy
+3
New +$42 ﹤0.01% 7267
2024
Q4 		– Hold
0
– -$4 – 7654
2024
Q3 		– Hold
0
– – – 7338
2024
Q2 		– Sell
-10
Closed -$468 – 7248
2024
Q1 		$484 Sell
10
-6
-38% -$297 ﹤0.01% 6723
2023
Q4 		$446 Hold
16
– – ﹤0.01% 6941
2023
Q3 		$780 Sell
16
-180
-92% -$11.7K ﹤0.01% 6674
2023
Q2 		$19K Sell
196
-12
-6% -$1.59K ﹤0.01% 5929
2023
Q1 		$25K Sell
208
-12
-5% -$1.47K ﹤0.01% 5929
2022
Q4 		$25K Sell
220
-86
-28% -$12K ﹤0.01% 5819
2022
Q3 		$47K Buy
+306
New +$45.1K ﹤0.01% 5568

Other funds holding PMN

ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DEM
Disciplined Equity Management Neptune Beach, Florida $199M AUM 20.69% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase's PMN Position: Q4 2025 in Review

JP Morgan Chase sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 3 shares — an estimated $29 sold.

JP Morgan Chase first reported a position in PMN in Q3 2022 and held it in 8 quarters. The position peaked at $47K in Q3 2022. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

  • JP Morgan Chase reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 3 ProMIS Neurosciences shares in Q4 2025, an estimated $29.
  • JP Morgan Chase first reported a position in ProMIS Neurosciences in Q3 2022 and held it in 8 quarters.
  • JP Morgan Chase's ProMIS Neurosciences position peaked at $47K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.